Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
14m agoAmesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
15m agoCreator Platform Beats Global Field Two Years Running, as Social Content Evolves into Social Commerce
15m agoAmerican Rebel Holdings (NASDAQ: AREB) Announces Nasdaq Trading Resumption and Provides Shareholder Update
16m agoPersonalization at Scale: 3,000 Custom Baseballs, One Unforgettable Adobe Summit
16m agoFirst Commerce Bancorp, Inc. Reports First Quarter 2026 Results and Declares a Cash Dividend
Cipher Pharmaceuticals Inc logo

Cipher Pharmaceuticals Inc

About

Cipher Pharmaceuticals Inc (TO:CPH) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 12 2026
Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings
Mar 4 2026
Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call
Jan 28 2026
Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba™ (Spinosad)
Jan 28 2026
Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba(TM) (Spinosad)
Nov 6 2025
Cipher Pharmaceuticals Reports Third Quarter 2025 Results

Financials

Revenue
CA$50.45 M
Market Cap
CA$485.32 M
P/E Ratio
13.10
EPS
1.46

Community Chat

Ask AI

6ix6ix